Regentis Biomaterials Ltd. RGNT

Healthcare — Medical Instruments & Supplies

1.98 (0.06) (2.94%) as of 25 Sep

Market cap: $15.8M
P/E: —

Follow RGNT

Overview Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Dec '24	Jun '25	Dec '25	Jun '26
ROE Full definition →	+1 more TTM period Free account	—	—	—	0.00%
ROA Full definition →		—	—	—	0.00%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Free Cash Flow per Share Full definition →		—	—	0.00	0.00
Free Cash Flow Full definition →		—	—	(3.58)	(5.20)
Capital Expenditures Full definition →		—	—	—	(0.03)
Piotroski F-Score Full definition →		—	0.00	0.00	0.00
Other line items
Cash ROIC Full definition →		0.00%	0.00%	(26.85%)	(31.04%)
Accounts Payable Turnover Full definition →		—	—	—	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →		—	—	0.00	0.00
Depreciation/Fixed assets Full definition →		—	—	—	0.16
Capex/Depreciation Full definition →		—	—	—	(6.60)
Operating CF per Share Full definition →		—	—	0.00	0.00
Capex per Share Full definition →		—	—	—	0.00
Capex to Sales Full definition →		—	—	—	0.00

Fold the line items

Columns are period end dates